It was a busy week for the Contemporary OB/GYN® team.
This week's top articles included:
A webinar held by the Kaiser Family Foundation (KFF) in April shared highlights from the 2020 Women’s Health Survey, followed by a panel discussion on its implications in several areas. This article captures the discussion portion of the webinar.
“GO MOMs will set the foundation for determining future approaches to the screening, diagnosis, and eventually, the treatment of elevated blood glucose during pregnancy,” said NIDDK program director Barbara Linder, MD, PHD, the project scientist for the study.
Join Senior Editor Angie DeRosa as Sarah J. Kilpatrick, MD, PhD; and Christian M. Pettker, MD debate noun use. Should ob/gyns use the terms, "pregnant women" or "pregnant persons?" Let us know what you think via Twitter @ContempOBGYN.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More